Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02987504
Title Study of Samalizumab in Patients With Advanced Cancer
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Alexion Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
New Haven Connecticut 06510 United States Details
Grand Rapids Michigan 49503 United States Details
San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field